Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A Systematic Review of Pharmacological Pain Management in Multiple Sclerosis.
Signaling through ERK1/2 Controls Myelin Thickness during Myelin Repair in the Adult Central Nervous System.
What's in the Literature?
Ice Pick Headache.
Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
P2X Receptors as Drug Targets.
The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model.
Adrenergic regulation of innate immunity: a review.
Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System.
Role of myelin sheath energy metabolism in neurodegenerative diseases.
Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.
Natalizumab (TYSABRI) and multiple sclerosis. With longer follow-up: even more toxic than suspected.
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis.
Central canal ependymal cells proliferate extensively in response to traumatic spinal cord injury but not demyelinating lesions.
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.
Support our campaign for better treatment for people with MS.
Self-reports of executive functioning in multiple sclerosis: to trust or not to trust.
Retrograde trans-synaptic degeneration in MS: A missing link?
Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis.
Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6.
Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone.
The fibrotic scar in neurological disorders.
Cost-effectiveness of an adjustment group for people with multiple sclerosis and low mood: a randomized trial.
Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis.

Pages